• 한국임상수의학회지
• /
• 제29권3호
• /
• pp.233-236
• /
• 2012

Cefquinome은 제4세대 cephalosporin으로 동물전용의약품으로 개발되었으며, ${\beta}$-lactamases에 대해서 매우 안정하고, 그람 음성 세균 및 양성 세균에 대한 광범위한 살균력을 가지고 있다. 본 연구는 현재 시판중인 cefquinome 주사제를 이유 자돈에 2 mg/kg 용량으로 근육 주사한 후 약물동태학적 특성을 파악하여 두 제제의 생물학적 동등성을 평가하였다. Cefquinome의 혈중 농도는 액체크로마토그래프/질량분석기를 이용하여 분석하였으며, 생물학적 동등성을 판정하기 위한 약물동태학적 인자로는 혈중 최고 농도 ($C_{max}$)와 혈장 농도 곡선하 면적 ($AUC_{0{\rightarrow}{\infty}}$)을 사용하였다. 시험약과 대조약의 혈중 최고 농도는 $4.34{\pm}0.58{\mu}g/mL$과 $4.22{\pm}0.47{\mu}g/mL$로 각각 나타났으며, 혈장 농도 곡선 하 면적은 $10.43{\pm}1.96{\mu}g{\cdot}h/mL$과 $10.25{\pm}2.98{\mu}g{\cdot}h/mL$로 관찰되었다. 로그변환한 약물동태학적 인자의 평균비율의 90% 신뢰 구간은 $C_{max}$의 경우 0.941-1.115이었고, $AUC_{0{\rightarrow}{\infty}}$의 경우 0.927-1.172로서 생물학적 동등성 기준인 0.8-1.25를 모두 만족시켰다. 이상의 결과로 시판중인 두 cefquinome 제제는 생물학적으로 동등하다고 판단된다.

• 대한원격탐사학회지
• /
• 제35권2호
• /
• pp.299-316
• /
• 2019

본 연구는 지리정보시스템(GIS) 환경에서 확률 모델인 Weight Of Evidence (WOE)와 Evidential Belief Function (EBF), 기계학습 모델인 Artificial Neural Networks (ANN) 모델을 이용하여 평창지역의 산사태 취약성도를 공간적으로 분석하고 예측하였다. 본 연구지역은 2006년 태풍 에위니아에 의한 집중호우로 산사태가 많이 발생하여 많은 재산 및 인명피해가 발생하였다. 산사태 취약성도를 작성하기 위해 항공사진을 이용하여 3,955개의 방대한 산사태 발생 위치를 탐지하였고, 환경공간정보인 지형, 지질, 토양, 산림 및 토지이용 등의 공간 데이터를 수집하여 공간데이터베이스에 구축하였다. 이러한 공간데이터베이스를 이용하여 산사태에 영향을 줄 수 있는 인자 17개를 추출하여 입력 인자와 EBF, WOE, ANN 모델을 이용하여 산사태 취약성도를 작성하고 검증하였다. 작성 및 검증을 위해 산사태 자료는 각각 50%씩 나누어서 훈련 및 검증을 실시하였고, 검증결과 WOE 모델의 경우는 74.73%, EBF 모델의 경우는 75.03%, ANN 모델의 경우는 70.87%의 예측 정확도를 나타내었다. 본 연구에 사용된 모델 중 EBF 모델이 가장 높은 정확도를 나타냈으며, 모든 모델에서 70% 이상의 예측 정확도를 보여 본 연구에서 사용된 기법이 산사태 취약성도 작성에 유효함을 나타내었다. 본 연구에서 제안된 WOE, EBF, ANN 모델과 산사태 취약성도는 이전에 산사태가 발생하지 않은 지역의 산사태를 예측하는 데 사용될 수 있다. 이러한 취약성도는 산사태 위험 감소를 촉진하고, 토지 이용 정책 및 개발을 위한 기초자료 역할을 할 수 있으며, 궁극적으로 산사태 재해 예방을 위한 시간과 비용을 절약할 수 있다. 향후 보다 많은 지역에서 산사태 취약성도 작성 방법을 적용하여 산사태 위험 예측을 위한 일반화된 모델을 이끌어 내야 한다.

• Investigative Magnetic Resonance Imaging
• /
• 제21권1호
• /
• pp.9-19
• /
• 2017

Background: Normalized cerebral blood volume (nCBV) can be measured using manual or semiautomatic segmentation method. However, the difference in diagnostic performance on brain tumor differentiation between differently measured nCBV has not been evaluated. Purpose: To compare the diagnostic performance of manually obtained nCBV to that of semiautomatically obtained nCBV on glioblastoma (GBM) and primary central nervous system lymphoma (PCNSL) differentiation. Materials and Methods: Histopathologically confirmed forty GBM and eleven PCNSL patients underwent 3T MR imaging with dynamic susceptibility contrast-enhanced perfusion MR imaging before any treatment or biopsy. Based on the contrast-enhanced T1-weighted imaging, the mean nCBV (mCBV) was measured using the manual method (manual mCBV), random regions of interest (ROIs) placement by the observer, or the semiautomatic segmentation method (semiautomatic mCBV). The volume of enhancing portion of the tumor was also measured during semiautomatic segmentation process. T-test, ROC curve analysis, Fisher's exact test and multivariate regression analysis were performed to compare the value and evaluate the diagnostic performance of each parameter. Results: GBM showed a higher enhancing volume (P = 0.0307), a higher manual mCBV (P = 0.018) and a higher semiautomatic mCBV (P = 0.0111) than that of the PCNSL. Semiautomatic mCBV had the highest value (0.815) for the area under the curve (AUC), however, the AUCs of the three parameters were not significantly different from each other. The semiautomatic mCBV was the best independent predictor for the GBM and PCNSL differential diagnosis according to the stepwise multiple regression analysis. Conclusion: We found that the semiautomatic mCBV could be a better predictor than the manual mCBV for the GBM and PCNSL differentiation. We believe that the semiautomatic segmentation method can contribute to the advancement of perfusion based brain tumor evaluation.

• Archives of Plastic Surgery
• /
• 제34권4호
• /
• pp.466-470
• /
• 2007

Purpose: Active prevention is an essential component in reducing the development of pressure sores. For the high-risk patient group, following the certified pressure sore screening scale as well as educating the patient and the nurses who care for them can lead to optimal management of these patients. Applying a risk assessment scale along with a prevention strategy can reduce medical costs and length of stays at the hospital. The purpose of this study is to evaluate the efficacy of a new pressure sore risk assessment scale based on the universally recommended Braden scale and our prevention program. Methods: From June to August, 2003, our pressure ulcer risk assessment scale was applied to a total of 1882 patients admitted to the experimental group (intensive care unit, neurosurgery, general surgery, and oncology units). It was based on Braden scale. We analysed sensitivity, specificity, positive and negative predictive value and ROC curve to evaluate its efficacy. Pressure ulcer prevention program was composed of patient's education using protocol and specific nursing care. The incidence of pressure ulcers was also measured during the 3 months period, and those were compared to the control group of 1789 patients from March to May, 2002. Results: 118(6.27%) of the experimental group were high-risk with an incidence of pressure ulcers measuring 4 (0.21%). Sensitivity, specificity, positive and negative predictive value of our scale were 100%, 94%, 4%, 100%, respectively, and AUC(area under the curve) was 0.992. In the control group, the incidence of pressure ulcers was 11(0.61%). Statistical analyses using chisquared tests with a significance level of 5%, the results were such that ${\chi }^2=3.6482$(p=0.0561). The results proved to be statistically significant in borderline. Conclusion: The results from this study proved that pressure sore risk assessment scale based on Braden scale has an excellent efficacy, and shows that our pressure ulcer prevention program is partially effective in reducing pressure ulcer incidence.

• Tuberculosis and Respiratory Diseases
• /
• 제62권6호
• /
• pp.499-505
• /
• 2007

배 경: TREM-1은 중성구, 단핵구, 대식세포 표면에 존재하는 세포표면수용체로, 세균에 의해 그 발현이 증가하여 여러 염증전달물질을 증폭시키는 역할을 한다. 저자들은 삼출성흉수를 가진 환자의 혈청과 흉수에서 soluble (s) TREM-1을 측정하여 흉수의 원인진단에 대한 유용성을 알아보고자 하였다. 방 법: 2003년 3월부터 2006년 12월까지 삼출성흉수로 입원한 환자 45명을 대상으로 하여, 혈청과 흉수에서 human sTREM-1 항체를 사용하여 면역점적법(immunoblot assay)으로 sTREM-1을 측정하였다. 원인질환에 따라 결핵성, 부폐렴성, 악성흉수로 나누어 비교하였다. 결 과: 혈청 sTREM-1은 원인질환 별로 유의한 차이를 보이지 않았으나, 흉수 sTREM-1은 원인질환별로 유의한 차이를 보였으며(p=0.011), 특히 부폐렴성흉수의 sTREM-1이 결핵성흉수와(p<0.05) 악성흉수보다 유의하게 높았다(p<0.05). 부폐렴성흉수를 진단하는 데 흉수 sTREM-1의 유용성을 평가하고자 ROC 곡선을 그린 결과 곡선밑면적은 0.818이고 (p=0.001), 흉수 sTREM-1의 cutoff 값을 103.5pg/mL로 하였을 때 민감도가 73%, 특이도가 81%이었다. 결 론: 흉수의 sTREM-1은 삼출성흉수 중 부폐렴성흉수를 진단하는 유용한 지표로 판단된다.

• Journal of Trauma and Injury
• /
• 제27권4호
• /
• pp.133-138
• /
• 2014

Purpose: If the survival of patients suffering from severe blunt trauma is to be improved, appropriate interventions should be taken immediately. The purpose of this study is to evaluate the clinical utility of end-tidal carbon dioxide ($ETCO_2$) as a surrogate marker for predicting both the need for intervention and the prognosis. Methods: This is a prospective observational study. Nasal cannula was applied to measure $ETCO_2$, and the following parameters, which are known to be related to the prognosis for a patient, were recorded: injury severity score (ISS), revised trauma score (RTS), arterial blood gas (ABG), lactate, and hemoglobin (Hb). To evaluate the outcome, we investigated the details of emergent interventions and expired patients. Results: A total of 93 patients were enrolled in this study. Emergent intervention was significantly associated with systolic blood pressure (sBP, p-value=0.001), $ETCO_2$ (p-value<0.001), serum lactate level (p-value<0.001), pH (p-value< 0.003), $HCO_3$ (p-value=0.004), base excess (p-value<0.002), ISS (p-value<0.001) and RTS (p-value=0.005). In the multivariate logistic regression, only $ETCO_2$ (odds ratio (OR): 0.897, 95% confidence interval (CI): 0.792-0.975, p-value= 0.048) and ISS (OR: 1.132, 95% CI: 1.053-1.233, p-value=0.002) were associated with emergent intervention whereas $ETCO_2$ (p-value=0.973) and ISS (p-value=0.511) were not statistically significant in predicting the survival of patients in the univariate analysis. An optimal ETCO cut-off of 29 mmHg on the ROC curve was determined, with the area under the ROC curve (AUC) being 0.824 (0.732-0.917)]. Conclusion: This study has revealed that $ETCO_2$, which can be rapid and easily measured through a nasal cannula, and the ISS may be prognostic indicators of emergent interventions in Emergency Departments.

• 대한소아치과학회지
• /
• 제42권1호
• /
• pp.30-37
• /
• 2015

새로운 우식 활성 비색 검사인 $Cariview^{(R)}$는 새로운 pH 지시약을 사용해서 치태 세균의 산 생산 능력을 더 잘 반영할 수 있다. 본 연구는 소아에서 $Cariview^{(R)}$와 치아 우식 경험(dmft index)과의 상관성을 평가하고, $Cariview^{(R)}$를 Dentocult $SM^{(R)}$과 비교할 목적으로 수행되었다. 만5세 이하 135명의 소아를 대상으로 dmft를 기록했으며, $Cariview^{(R)}$와 Dentocult $SM^{(R)}$ 두 가지 우식 활성 검사를 제조사 지시에 따라 시행하였다. 그 결과, $Cariview^{(R)}$는 소아의 치아 우식 경험과 중등도의 상관관계를 보였다(r = 0.43, p < 0.01). 치아 우식증 예측에 있어 $Cariview^{(R)}$는 민감도 68.8%, 특이도 69.2%, ROC 곡선 분석의 곡선하면적(AUC) 0.686으로 Dentocult $SM^{(R)}$에 비해 양호한 수치를 보였다. $Cariview^{(R)}$는 비협조적인 어린이에게도 시행이 쉽고 편리하며 시각적인 색상으로 나타나 구강위생교육 도구로서 가치가 있다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권4호
• /
• pp.1403-1407
• /
• 2015

Background: New tumour biomarkers are being intensely investigated for malignant mesothelioma (MM). Fibulin-3 is produced in MM but its role remains uncertain. The aim of this study was to evaluate the validity of measuring serum fibulin-3 in the diagnosis and prognosis of MM. Materials and Methods: This prospective study was performed on 43 patients and 40 healthy controls who were admitted to our hospital between January 2012 and January 2014. Data from MM patients, including demographic and clinical features, routine laboratory data, levels of serum fibulin-3, and treatment outcomes were defined as potential prognostic factors. The receiver operating characteristic (ROC) curve for fibulin-3 was used to detect the cut-off value with highest sensitivity and specificity. Univariate survival analysis was performed using the Kaplan-Meier method in patients with MM. Afterwards, the possible factors identified with univariate analyses were entered into the cox regression analysis. Results: Our results revealed that patients with MM had significantly higher serum levels of fibulin-3 than controls. The results showed that the best cut-off point was 36.6 ng/ml with an AUC (area under the curve)=0.976, sensitivity=93.0% and specificity=90.0. In our study, the initial significant poor prognostic factors were advanced stage, high white blood cell count, high platelet count, high C-reactive protein (p<0.05 for each variable). Later, according to multivariate analysis the results showed only advanced stage as significant parameter (p=0.040). Conclusions: We determined that real use for serum fibulin-3 was not for prognosis but for diagnosis in MM. Also advanced stage was associated with poor MM prognosis.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권8호
• /
• pp.3407-3412
• /
• 2015

Background: The aim of this study was to evaluate and compare the accuracy of diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC) value, and time-intensity curve (TIC) type analysis derived from dynamic contrast-enhanced MR imaging (DCE-MRI) in differentiating benign from malignant adnexal masses. Materials and Methods: 47 patients with 56 adnexal masses (27 malignant and 29 benign) underwent DWI and DCE-MRI examinations, prior to surgery. DWI signal intensity, mean ADC value, and TIC type were determined for all the masses. Results: High signal intensity on DWI and type 3 TIC were helpful in differentiating benign from malignant adnexal masses (p<0.001). The mean ADC value was significantly lower in malignant adnexal masses (p<0.001). An ADC value< $1.20{\times}10^{-3}mm^2/s$ may be the optimal cutoff for differentiating between benign and malignant tumors. The negative predictive value for low signal intensity on DWI, and type 1 TIC were 100%. The pairwise comparison among the receiver operating characteristic (ROC) curves showed that the area under the curve (AUC) of TIC was significantly larger than the AUCs of DWI and ADC (p<0.001 for comparison of TIC and DWI, p<0.02 for comparison of TIC and ADC value). Conclusions: DWI, ADC value and TIC type derived from DCE-MRI are all sensitive and relatively specific methods for differentiating benign from malignant adnexal masses. By comparing these functional MR techniques, TIC was found to be more accurate than DWI and ADC.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권3호
• /
• pp.2053-2058
• /
• 2013

Background: Formation of new blood vessels is necessary for the development and spread of neoplasms more than 1 mm3 in volume, angiogenesis being responsible for formation of new from pre-existing blood vessels. Vascular endothelial growth factor (VEGF) is pivotal and the best studied angiogenic factor in all human cancers. Therefore we designed this study to investigate the role of VEGF-A and VEGF-C in prostate cancer in comparison with BPH controls in a north Indian population. Methods: In this case-control study a total of 100 subjects were included on the basis of confirmed histopathological reports, out of which 50 were prostate cancer patients and the other 50 were BPH patients with PSA levels >2 ng/ml and abnormal digital rectal examination (DRE) findings during September 2009 to August 2011 from the Department of Urology, KGMU, Lucknow, India. Plasma levels of VEGF were determined using quantitative immunoassay (ELISA-enzyme linked immunosorbent assay). Statistical analysis was carried out using SPSS 15.0 version. Results: The mean age of prostate cancer ($67.6{\pm}5.72$) patients was significantly higher (p=0.005) than BPH ($63.6{\pm}7.92$) patients. Expression of VEGF-A was not significantly higher in disease stage C1 than D1 or D2 and A or B (p=0.13) while the level of VEGF-A was significantly higher (p=0.04) in prostate cancer as compared to BPH subjects (PCa=13.0 pg/ml, BPH=6.8 pg/ml). Levels of VEGF-C were similar in both groups (PCa=832.6 pg/ml, BPH=823.7 pg/ml). In ROC curve, the area under curve (AUC) was 0.70 (95%CI: 0.60-0.80) and the cut-off value for which a higher proportion of patients was correctly classified (20%) was 26.0 pg/mL. Conclusion: Although VEGF-A is increased in cancer prostate patients a statistically significant correlation could not be established in this study. VEGF-C was not found to be a useful biomarker.